.
.eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention..
one thought on “chess grandmasters show the same longevity advantage as elite athletes”..
"the treatment of our family and the behaviour of the western trust has been disgraceful, they should be ashamed of themselves..